Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Return on Assets (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Return on Assets for 12 consecutive years, with 0.23% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 26.0% to 0.23% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.23% through Dec 2025, up 26.0% year-over-year, with the annual reading at 0.25% for FY2025, 28.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.23% at Theravance Biopharma, up from 0.18% in the prior quarter.
  • The five-year high for Return on Assets was 1.81% in Q2 2023, with the low at 0.49% in Q1 2021.
  • Average Return on Assets over 5 years is 0.31%, with a median of 0.06% recorded in 2025.
  • The sharpest move saw Return on Assets soared 184bps in 2022, then tumbled -194bps in 2024.
  • Over 5 years, Return on Assets stood at 0.17% in 2021, then skyrocketed by 734bps to 1.41% in 2022, then crashed by -110bps to 0.14% in 2023, then skyrocketed by 80bps to 0.03% in 2024, then soared by 952bps to 0.23% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.23%, 0.18%, and 0.16% for Q4 2025, Q3 2025, and Q2 2025 respectively.